173 related articles for article (PubMed ID: 37820086)
1. New strategies for the treatment of breast cancer with leptomeningeal metastasis.
Chew SM; Seidman AD
Curr Opin Oncol; 2023 Nov; 35(6):500-506. PubMed ID: 37820086
[TBL] [Abstract][Full Text] [Related]
2. Management of leptomeningeal metastasis in breast cancer.
Assi HI; Mahmoud T; Saadeh FS; El Darsa H
Clin Neurol Neurosurg; 2018 Sep; 172():151-159. PubMed ID: 30015053
[TBL] [Abstract][Full Text] [Related]
3. [Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?].
Gutierrez M; Lyazidi S; Brasseur L; Cvitkovic F; Le Scodan R
Bull Cancer; 2011 Apr; 98(4):417-24. PubMed ID: 21540147
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for leptomeningeal disease in breast cancer.
Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
[TBL] [Abstract][Full Text] [Related]
5. The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: A systematic review and pooled analysis.
Lee YC; Hsieh CC; Chuang JP; Li CY
Curr Probl Cancer; 2017; 41(5):355-370. PubMed ID: 28779849
[TBL] [Abstract][Full Text] [Related]
6. Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases.
Angus L; Deger T; Jager A; Martens JWM; de Weerd V; van Heuvel I; van den Bent MJ; Sillevis Smitt PAE; Kros JM; Bindels EMJ; Heitzer E; Sleijfer S; Jongen JLM; Wilting SM
Clin Cancer Res; 2021 May; 27(10):2798-2806. PubMed ID: 33514525
[TBL] [Abstract][Full Text] [Related]
7. Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities.
Kak M; Nanda R; Ramsdale EE; Lukas RV
J Clin Neurosci; 2015 Apr; 22(4):632-7. PubMed ID: 25677875
[TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal metastasis from systemic cancer: Review and update on management.
Wang N; Bertalan MS; Brastianos PK
Cancer; 2018 Jan; 124(1):21-35. PubMed ID: 29165794
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal carcinomatosis in patients with breast cancer.
Franzoi MA; Hortobagyi GN
Crit Rev Oncol Hematol; 2019 Mar; 135():85-94. PubMed ID: 30819451
[TBL] [Abstract][Full Text] [Related]
11. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY; Chung WK; Oh IJ
Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
[TBL] [Abstract][Full Text] [Related]
13. Breast leptomeningeal disease: a review of current practices and updates on management.
Figura NB; Rizk VT; Armaghani AJ; Arrington JA; Etame AB; Han HS; Czerniecki BJ; Forsyth PA; Ahmed KA
Breast Cancer Res Treat; 2019 Sep; 177(2):277-294. PubMed ID: 31209686
[TBL] [Abstract][Full Text] [Related]
14. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
15. Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases.
Wilcox JA; Boire AA
CNS Drugs; 2023 Jan; 37(1):45-67. PubMed ID: 36474108
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.
Morikawa A; Jordan L; Rozner R; Patil S; Boire A; Pentsova E; Seidman AD
Clin Breast Cancer; 2017 Feb; 17(1):23-28. PubMed ID: 27569275
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
18. Management of leptomeningeal carcinomatosis and challenges of trial design.
Gill CM; Brastianos PK
Curr Opin Oncol; 2019 Nov; 31(6):508-513. PubMed ID: 31503030
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis.
Park WY; Kim HJ; Kim K; Bae SB; Lee N; Lee KT; Won JH; Park HS; Lee SC
Cancer Res Treat; 2016 Apr; 48(2):843-7. PubMed ID: 25761487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]